Find the latest clinical trials by condition, location & phase
Browse and search for drug information and related clinical trials
Explore a comprehensive list of organizations, including their profiles and details.
Latest updates on clinical trials, pharmaceuticals, and healthcare companies
Stay informed with timely notifications on clinical trials and research advancements.
No overview information available.
No background information available.
No indication information available.
No associated conditions information available.
Roivant Sciences has launched Pulmovant, a new venture focused on developing mosliciguat for pulmonary hypertension associated with interstitial lung disease (PH-ILD).
Roivant Sciences has acquired mosliciguat, an experimental drug, from Bayer to develop as a treatment for pulmonary hypertension.